Advertisements


Biotech Analysis Central Pharma News: Pain"s Positive Remoxy Data, Celgene"s Massive Acquisition, Novavax Makes Stride With RSV Vaccine

Biotech Analysis Central Pharma News: Pain"s Positive Remoxy Data, Celgene"s Massive Acquisition, Novavax Makes Stride With RSV Vaccine.....»»

Category: topSource: seekingalphaJan 11th, 2018

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»

Category: topSource: seekingalphaApr 9th, 2018

Biotech Analysis Central Pharma News: Merck"s Keytruda Rises, Celgene"s Possible Next Move, Eiger"s Phase 2 Dip

Biotech Analysis Central Pharma News: Merck"s Keytruda Rises, Celgene"s Possible Next Move, Eiger"s Phase 2 Dip.....»»

Category: topSource: seekingalphaJan 17th, 2018

Biotech Analysis Central Pharma News: Merck And Pfizer"s Green Light, Biogen"s Woes, Rxi Pharmaceuticals Scar Data

Biotech Analysis Central Pharma News: Merck And Pfizer"s Green Light, Biogen"s Woes, Rxi Pharmaceuticals Scar Data.....»»

Category: topSource: seekingalphaDec 22nd, 2017

Biotech Analysis Central Pharma News: AbbVie And Roche Stellar Data, Aduro Pulls The Cord, Allergan"s Bargain Bin Buy

Biotech Analysis Central Pharma News: AbbVie And Roche Stellar Data, Aduro Pulls The Cord, Allergan"s Bargain Bin Buy.....»»

Category: topSource: seekingalphaDec 14th, 2017

Biotech Analysis Central Pharma News: Bluebird Bio"s Success, Spark"s Hemophilia Data, Verastems Results

Biotech Analysis Central Pharma News: Bluebird Bio"s Success, Spark"s Hemophilia Data, Verastems Results.....»»

Category: topSource: seekingalphaDec 12th, 2017

Biotech Analysis Central Pharma News: Galectin"s Failure, Revance"s Positive Results, Novo Nordisk"s FDA Win

Biotech Analysis Central Pharma News: Galectin"s Failure, Revance"s Positive Results, Novo Nordisk"s FDA Win.....»»

Category: topSource: seekingalphaDec 6th, 2017

Biotech Analysis Central Pharma News: Merck"s Keytruda Breakthrough, Bristol Myers And JNJ Team Up, Alkermes Gets A Second Shot

Biotech Analysis Central Pharma News: Merck"s Keytruda Breakthrough, Bristol Myers And JNJ Team Up, Alkermes Gets A Second Shot.....»»

Category: topSource: seekingalphaApr 17th, 2018

Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex"s Failure

Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex"s Failure.....»»

Category: topSource: seekingalphaApr 17th, 2018

Biotech Analysis Central Pharma News: Novartis"s Gene Therapy Catch, AstraZeneca"s NASH Move, Clovis"s Expanded Rubraca Market

Biotech Analysis Central Pharma News: Novartis"s Gene Therapy Catch, AstraZeneca"s NASH Move, Clovis"s Expanded Rubraca Market.....»»

Category: topSource: seekingalphaApr 11th, 2018

Biotech Analysis Central Pharma News: Takeda"s Potential Bid, Alkermes Setback, MediciNova Impresses

Biotech Analysis Central Pharma News: Takeda"s Potential Bid, Alkermes Setback, MediciNova Impresses.....»»

Category: topSource: seekingalphaApr 3rd, 2018

Biotech Analysis Central Pharma News: bluebird Bio Teams Up; Galectin"s Advance; Pfizer"s Late-Stage Win

Biotech Analysis Central Pharma News: bluebird Bio Teams Up; Galectin"s Advance; Pfizer"s Late-Stage Win.....»»

Category: topSource: seekingalphaApr 3rd, 2018

Biotech Analysis Central Pharma News: Regeneron And Alnylam Team Up, Zealand"s Rescue Pen Succeeds, AbbVie"s Hope Remains With Rova-T Prospects

Biotech Analysis Central Pharma News: Regeneron And Alnylam Team Up, Zealand"s Rescue Pen Succeeds, AbbVie"s Hope Remains With Rova-T Prospects.....»»

Category: topSource: seekingalphaMar 24th, 2018

Biotech Analysis Central Pharma News: Conatus Leaps On Upgrade, Reata Fails Mid-Stage Study, Synergy"s Strategy Shift

Biotech Analysis Central Pharma News: Conatus Leaps On Upgrade, Reata Fails Mid-Stage Study, Synergy"s Strategy Shift.....»»

Category: topSource: seekingalphaMar 5th, 2018

Biotech Analysis Central Pharma News: Bristol-Myers Squibb"s Push On Lung Cancer, EyeGate"s Blow Up, Roche"s Advance In Kidney Cancer

Biotech Analysis Central Pharma News: Bristol-Myers Squibb"s Push On Lung Cancer, EyeGate"s Blow Up, Roche"s Advance In Kidney Cancer.....»»

Category: topSource: seekingalphaFeb 6th, 2018

Biotech Analysis Central Pharma News: Aradigm"s FDA Rejection, Sanofi"s Extra Buy, Theravance And Mylan"s FDA Push

Biotech Analysis Central Pharma News: Aradigm"s FDA Rejection, Sanofi"s Extra Buy, Theravance And Mylan"s FDA Push.....»»

Category: topSource: seekingalphaJan 30th, 2018

Biotech Analysis Central Pharma News: Roche"s MS Win, Aradigm FDA Panel Woes, AstraZeneca"s Expanded Indication

Biotech Analysis Central Pharma News: Roche"s MS Win, Aradigm FDA Panel Woes, AstraZeneca"s Expanded Indication.....»»

Category: topSource: seekingalphaJan 15th, 2018

Biotech Analysis Central Pharma News: Allergan"s Restasis Trouble, Mylan"s Advance On Teva, Pfizer"s Alzheimer"s Exit

Biotech Analysis Central Pharma News: Allergan"s Restasis Trouble, Mylan"s Advance On Teva, Pfizer"s Alzheimer"s Exit.....»»

Category: topSource: seekingalphaJan 8th, 2018

Biotech Analysis Central Pharma News: Spark"s Pricing Woes, Novartis" Breast Cancer Advance, Sangamo"s Partnership With Pfizer

Biotech Analysis Central Pharma News: Spark"s Pricing Woes, Novartis" Breast Cancer Advance, Sangamo"s Partnership With Pfizer.....»»

Category: topSource: seekingalphaJan 3rd, 2018

Biotech Analysis Central Pharma News: Protalix Phase 2 Success, Achaogen NDA Acceptance, GW Pharmaceuticals FDA Advance

Biotech Analysis Central Pharma News: Protalix Phase 2 Success, Achaogen NDA Acceptance, GW Pharmaceuticals FDA Advance.....»»

Category: topSource: seekingalphaJan 3rd, 2018

Biotech Analysis Central Pharma News: Agile CRL, Roche"s Purchase, Mallinckrodt"s Major Buy

Biotech Analysis Central Pharma News: Agile CRL, Roche"s Purchase, Mallinckrodt"s Major Buy.....»»

Category: topSource: seekingalphaDec 28th, 2017